Fluticasone/salm Inh 230/21mcg 120s
Overview
What is this medicine?
How to Use This Medicine
To use this medication safely and effectively, follow your doctor's instructions and the information provided with your prescription. Use this inhaler only for breathing in, as directed by your healthcare provider. Continue using this medication even if you feel well, and take it at the same time every day.
After each use, rinse your mouth with water and spit it out - do not swallow the rinse water. If you are using multiple inhaled medications, consult your doctor about which one to use first.
Preparing and Using Your Inhaler
Before using your inhaler for the first time, shake it well and spray 4 test sprays into the air, away from your face. If you haven't used your inhaler in over 4 weeks or if it's been dropped, shake it well and spray 2 test sprays into the air, away from your face, before using it again. Always replace the cap after taking your dose.
Important Safety Precautions
This medication is flammable, so do not use it near an open flame or while smoking. Some inhalers have a dose counter to track the number of doses remaining. If your inhaler has a dose counter, dispose of it when the counter reaches "0".
Storing and Disposing of Your Medication
Store your inhaler at room temperature in a dry place, away from bathrooms. Keep the mouthpiece facing down.
Missing a Dose
If you miss a dose, skip it and take your next dose at the usual time. Do not take two doses at once or take extra doses to make up for a missed dose.
Lifestyle & Tips
- Use regularly, even if you feel well, to get the full benefit.
- Rinse your mouth with water and spit it out after each dose to prevent oral thrush (yeast infection). Do not swallow the water.
- Do not use for sudden breathing problems; always carry a fast-acting rescue inhaler (e.g., albuterol) for acute symptoms.
- Do not exceed the prescribed dose or use more often than twice daily.
- Avoid triggers that worsen your asthma or COPD (e.g., smoke, allergens, air pollution).
- Maintain good hydration and nutrition.
- Regular exercise as tolerated and advised by your doctor.
Available Forms & Alternatives
Available Strengths:
- Fluticasone/salmeterol 55/14mcg In
- Flutic/salmeterol 113/14mcg Inh(60)
- Flutic/salmet 232-14mcg 60 Puffs
- Fluticasone/salm Disk 100/50mcg 60s
- Fluticasone/salm Disk 250/50mcg 60s
- Fluticasone/salm Disk 500/50mcg 60s
- Fluticasone/salm 115/21mcg Inh 120s
- Fluticasone/salm Inh 230/21mcg 120s
- Fluticasone/salm Inh 45/21mcg 120s
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction: rash, hives, itching, red, swollen, blistered, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, difficulty breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat
Signs of infection: fever, chills, severe sore throat, ear or sinus pain, cough, increased or changed sputum production, painful urination, mouth sores, or a wound that won't heal
Signs of high blood sugar: confusion, drowsiness, excessive thirst or hunger, frequent urination, flushing, rapid breathing, or fruity-smelling breath
Signs of low potassium levels: muscle pain or weakness, muscle cramps, or an irregular heartbeat
Signs of a weak adrenal gland: severe nausea or vomiting, extreme dizziness or fainting, muscle weakness, fatigue, mood changes, decreased appetite, or weight loss
Signs of high or low blood pressure: severe headache or dizziness, fainting, or changes in vision
Chest pain or pressure
Rapid or abnormal heartbeat
Shakiness
Feeling nervous or agitated
Changes in behavior
Vision changes, eye pain, or severe eye irritation
Abnormal burning, numbness, or tingling sensations
Choking
Voice changes
Seizures
Bone pain
Sleep disturbances
Feeling extremely tired or weak
Vaginal itching or discharge
Weight gain
Mouth irritation or mouth sores
Redness or white patches in the mouth or throat
Important: This medication can cause severe breathing problems, which may be life-threatening. If you experience difficulty breathing, worsening breathing, wheezing, or coughing after taking this medication, use a rescue inhaler and seek immediate medical attention.
Other Possible Side Effects
Most medications can cause side effects, but many people experience none or only mild symptoms. If you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical attention if they bother you or persist:
Headache
Nausea or vomiting
Throat irritation
* Common cold symptoms
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Worsening shortness of breath or wheezing
- Increased need for your rescue inhaler
- Chest pain or fast/pounding heartbeat
- Severe headache
- Signs of infection (fever, chills, increased mucus, change in mucus color)
- White patches in your mouth or throat (oral thrush)
- Blurred vision or eye pain
- Swelling of your face, lips, or tongue (allergic reaction)
- Muscle cramps or weakness
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you are currently taking a similar medication. If you are unsure, consult your doctor or pharmacist for clarification.
Any prescription or over-the-counter (OTC) medications, natural products, or vitamins you are taking that may interact with this medication. Certain medications used to treat HIV, infections, depression, and other conditions should not be taken with this drug. Your doctor or pharmacist can advise you on potential interactions.
Please note that this is not an exhaustive list of all medications or health conditions that may interact with this drug.
To ensure your safety, it is crucial to discuss the following with your doctor and pharmacist:
All medications you are taking, including prescription and OTC medications, natural products, and vitamins.
Any health problems you have.
* You must verify that it is safe to take this medication with all your other medications and health conditions. Do not start, stop, or change the dose of any medication without first consulting your doctor.
Precautions & Cautions
If you have diabetes (high blood sugar), consult with your doctor, as this medication may increase your blood sugar levels. Immediately contact your doctor if your breathing problems worsen, your rescue inhaler becomes less effective, or you need to use it more frequently.
Do not exceed the recommended dose or use this medication more often than prescribed. Overdosing on this type of medication has been fatal. Consult with your doctor if you have any concerns.
When transitioning from an oral steroid to a different form of steroid, you may be at risk for severe and potentially life-threatening side effects. Be aware of symptoms such as weakness, fatigue, dizziness, nausea, vomiting, confusion, or low blood sugar, and contact your doctor immediately if you experience any of these.
In the event of a severe injury, surgery, or infection, you may require additional doses of oral steroids to help your body cope with the stress. Carry a warning card indicating that you may need extra steroids in certain situations.
Long-term use of this medication may increase your risk of developing cataracts or glaucoma. Discuss this with your doctor and follow their recommendations for regular eye exams.
Prolonged use of this medication may also lead to osteoporosis (weak bones). Consult with your doctor to determine your risk and address any concerns. Follow your doctor's advice regarding bone density tests.
You may be more susceptible to infections while taking this medication. To minimize this risk, practice good hygiene by washing your hands frequently and avoid close contact with people who have infections, colds, or flu.
If you have not previously had chickenpox or measles, avoid exposure to these illnesses, as they can be severe or even fatal in people taking steroid medications like this one. If you have been exposed to chickenpox or measles, consult with your doctor.
If you are 65 or older, use this medication with caution, as you may be more prone to side effects.
In some cases, this medication may affect growth in children and teenagers. Regular growth checks may be necessary, so discuss this with your doctor.
If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor to discuss the potential benefits and risks to you and your baby.
Overdose Information
Overdose Symptoms:
- Chest pain
- Fast or irregular heartbeat (palpitations)
- Tremor or nervousness
- Headache
- Dizziness
- Nausea
- Vomiting
- Muscle cramps
- Seizures
- Hypokalemia (low potassium)
- Hyperglycemia (high blood sugar)
- Exaggerated systemic corticosteroid effects (e.g., Cushing's syndrome symptoms, adrenal suppression) with chronic overdose
What to Do:
Seek immediate medical attention or call Poison Control at 1-800-222-1222. Treatment is supportive and symptomatic. May involve cardiac monitoring, potassium supplementation, and glucose management.
Drug Interactions
Contraindicated Interactions
- Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir, telithromycin)
Major Interactions
- Beta-blockers (non-cardioselective)
- Diuretics (thiazide or loop) - potential for hypokalemia
- Tricyclic antidepressants (TCAs)
- Monoamine oxidase inhibitors (MAOIs)
- Other long-acting beta2-agonists (LABAs)
Moderate Interactions
- Other adrenergic drugs
- QTc-prolonging drugs
- Xanthine derivatives (e.g., theophylline)
- Corticosteroids (systemic)
Minor Interactions
- Not specifically identified as minor, but general caution with drugs affecting electrolyte balance.
Monitoring
Baseline Monitoring
Rationale: To establish baseline lung function and assess disease severity.
Timing: Prior to initiation of therapy
Rationale: To establish baseline symptom frequency and severity.
Timing: Prior to initiation of therapy
Rationale: To monitor for potential systemic corticosteroid effects on growth.
Timing: Prior to initiation of therapy
Rationale: To screen for cataracts or glaucoma, especially with long-term ICS use.
Timing: Prior to initiation of therapy, if indicated
Routine Monitoring
Frequency: Periodically (e.g., every 3-12 months or as clinically indicated)
Target: Improvement from baseline, maintenance of optimal lung function
Action Threshold: Worsening FEV1, lack of improvement
Frequency: At each follow-up visit (e.g., every 1-3 months initially, then every 3-12 months)
Target: Reduced frequency of symptoms, reduced need for rescue medication
Action Threshold: Increased symptoms, increased rescue inhaler use, nocturnal awakenings
Frequency: At each follow-up visit
Target: Absence or minimal adverse effects
Action Threshold: Persistent or worsening adverse effects
Frequency: Regularly (e.g., every 3-6 months)
Target: Normal growth velocity for age
Action Threshold: Growth deceleration
Frequency: As clinically indicated
Target: 3.5-5.0 mEq/L
Action Threshold: <3.5 mEq/L
Frequency: As clinically indicated
Target: Normal fasting glucose
Action Threshold: Elevated glucose
Symptom Monitoring
- Increased shortness of breath
- Increased wheezing
- Increased cough
- Increased need for rescue inhaler (e.g., albuterol)
- Worsening of asthma/COPD symptoms at night
- Chest tightness
- Signs of oral thrush (white patches in mouth/throat)
- Hoarseness or voice changes
- Tremor or nervousness
- Palpitations or rapid heart rate
- Muscle cramps or weakness (potential hypokalemia)
- Blurred vision or eye pain (potential for glaucoma/cataracts)
Special Patient Groups
Pregnancy
Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Asthma control is important during pregnancy. Category C.
Trimester-Specific Risks:
Lactation
Caution should be exercised when administered to a nursing woman. Fluticasone and salmeterol are present in human milk. Consider the developmental and health benefits of breastfeeding along with the motherβs clinical need for the drug and any potential adverse effects on the breastfed infant.
Pediatric Use
Not indicated for children under 12 years for this specific strength (230/21 mcg). Lower strengths are approved for children 12 years and older with asthma. Monitor growth velocity in pediatric patients receiving inhaled corticosteroids.
Geriatric Use
No overall differences in safety or effectiveness have been observed between elderly and younger patients. However, elderly patients may be more susceptible to the effects of beta2-agonists (e.g., cardiovascular effects) and corticosteroids (e.g., bone density, cataracts, glaucoma). Use with caution and monitor closely.
Clinical Information
Clinical Pearls
- This combination inhaler is for maintenance therapy only and should not be used for acute bronchospasm. Patients should always have a short-acting beta2-agonist (SABA) for rescue.
- Proper inhaler technique is crucial for efficacy. Patients should be instructed on how to use the Diskus device correctly.
- Rinsing the mouth after each dose helps prevent oral candidiasis (thrush) and dysphonia.
- Patients should be advised not to stop therapy abruptly, especially if on high doses, due to the risk of adrenal insufficiency.
- The black box warning for LABAs applies, emphasizing that this product should not be used as monotherapy for asthma and is generally reserved for patients whose asthma is not adequately controlled on an ICS alone or whose disease severity warrants initiation of both an ICS and LABA.
- Monitor for systemic corticosteroid effects, especially with prolonged use of high doses (e.g., adrenal suppression, bone mineral density changes, cataracts, glaucoma, hyperglycemia).
Alternative Therapies
- Inhaled Corticosteroids (ICS) monotherapy (e.g., fluticasone propionate, budesonide, mometasone)
- Long-acting Muscarinic Antagonists (LAMAs) (e.g., tiotropium, umeclidinium) - primarily for COPD, sometimes add-on for asthma
- Leukotriene Receptor Antagonists (LTRAs) (e.g., montelukast)
- Oral corticosteroids (for severe exacerbations or refractory disease)
- Biologic therapies (e.g., omalizumab, mepolizumab, dupilumab) for severe asthma